Editorial: Lipid-lowering drugs after myocardial infarction.
D002784:Cholesterol / Q000097:blood; D002994:Clofibrate / Q000627:therapeutic use*; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008055:Lipids / Q000097:blood; D009203:Myocardial Infarction / Q000401:mortality / Q000517:prevention & control*; D009539:Nicotinic Acids / Q000627:therapeutic use*; D010919:Placebos; D014280:Triglycerides / Q000097:blood
D000960:Hypolipidemic Agents; D008055:Lipids; D009539:Nicotinic Acids; D010919:Placebos; D014280:Triglycerides; D002784:Cholesterol; D002994:Clofibrate